1. Home
  2. WASH vs MLYS Comparison

WASH vs MLYS Comparison

Compare WASH & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WASH
  • MLYS
  • Stock Information
  • Founded
  • WASH 1800
  • MLYS 2019
  • Country
  • WASH United States
  • MLYS United States
  • Employees
  • WASH N/A
  • MLYS N/A
  • Industry
  • WASH Major Banks
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WASH Finance
  • MLYS Health Care
  • Exchange
  • WASH Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • WASH 542.9M
  • MLYS 1.0B
  • IPO Year
  • WASH N/A
  • MLYS 2023
  • Fundamental
  • Price
  • WASH $28.51
  • MLYS $14.63
  • Analyst Decision
  • WASH Buy
  • MLYS Strong Buy
  • Analyst Count
  • WASH 4
  • MLYS 4
  • Target Price
  • WASH $32.25
  • MLYS $27.00
  • AVG Volume (30 Days)
  • WASH 150.8K
  • MLYS 885.1K
  • Earning Date
  • WASH 07-21-2025
  • MLYS 08-12-2025
  • Dividend Yield
  • WASH 7.78%
  • MLYS N/A
  • EPS Growth
  • WASH N/A
  • MLYS N/A
  • EPS
  • WASH N/A
  • MLYS N/A
  • Revenue
  • WASH $110,088,000.00
  • MLYS N/A
  • Revenue This Year
  • WASH $57.10
  • MLYS N/A
  • Revenue Next Year
  • WASH $8.91
  • MLYS N/A
  • P/E Ratio
  • WASH N/A
  • MLYS N/A
  • Revenue Growth
  • WASH N/A
  • MLYS N/A
  • 52 Week Low
  • WASH $24.95
  • MLYS $8.24
  • 52 Week High
  • WASH $40.59
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • WASH 48.80
  • MLYS 54.08
  • Support Level
  • WASH $29.25
  • MLYS $14.07
  • Resistance Level
  • WASH $30.15
  • MLYS $14.70
  • Average True Range (ATR)
  • WASH 0.68
  • MLYS 0.69
  • MACD
  • WASH 0.05
  • MLYS 0.15
  • Stochastic Oscillator
  • WASH 39.71
  • MLYS 80.69

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: